Segall Bryant & Hamill’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-44,698
| Closed | -$1.49M | – | 577 |
|
|
2017
Q2 | $1.49M | Sell |
44,698
-2,694
| -6% | -$89.5K | 0.04% | 332 |
|
|
2017
Q1 | $1.52M | Buy |
47,392
+800
| +2% | +$25.7K | 0.04% | 321 |
|
|
2016
Q4 | $1.69M | Sell |
46,592
-465
| -1% | -$16.9K | 0.04% | 308 |
|
|
2016
Q3 | $2.17M | Buy |
47,057
+5,000
| +12% | +$230K | 0.06% | 276 |
|
|
2016
Q2 | $2.11M | Sell |
42,057
-1,649
| -4% | -$82.8K | 0.06% | 279 |
|
|
2016
Q1 | $2.34M | Hold |
43,706
| – | – | 0.06% | 285 |
|
|
2015
Q4 | $2.87M | Hold |
43,706
| – | – | 0.07% | 273 |
|
|
2015
Q3 | $2.47M | Buy |
43,706
+36,355
| +495% | +$2.05M | 0.06% | 283 |
|
|
2015
Q2 | $434K | Sell |
7,351
-500
| -6% | -$29.5K | 0.01% | 439 |
|
|
2015
Q1 | $489K | Hold |
7,851
| – | – | 0.01% | 430 |
|
|
2014
Q4 | $452K | Hold |
7,851
| – | – | 0.01% | 435 |
|
|
2014
Q3 | $422K | Sell |
7,851
-1,050
| -12% | -$56.4K | 0.01% | 447 |
|
|
2014
Q2 | $467K | Buy |
8,901
+225
| +3% | +$11.8K | 0.01% | 445 |
|
|
2014
Q1 | $458K | Sell |
8,676
-1,030
| -11% | -$54.4K | 0.01% | 450 |
|
|
2013
Q4 | $389K | Sell |
9,706
-767
| -7% | -$30.7K | 0.01% | 478 |
|
|
2013
Q3 | $396K | Sell |
10,473
-834
| -7% | -$31.5K | 0.01% | 470 |
|
|
2013
Q2 | $443K | Buy |
+11,307
| New | +$443K | 0.01% | 415 |
|